The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
My starting weight was 142.4 pounds at 51
There are several mechanisms involved in TP53-mediated metabolic changes (158, 159)
If possible, also get fasting insulin and a thyroid panel (TSH, free T3, free T4)
The on-page COA library archives every lot indexed by that single identifier, so historical batch documentation can be retrieved by procurement reviewers or institutional auditors before any order is placed
Losing weight too quickly can sometimes lead to "Ozempic face" (loss of facial fat) or sagging skin